RTKN2 and hepatocellular carcinoma: At the same time, its potentially biological mechanism was explored that hsa_circRNA_104348 might function as a ceRNA candidate to promote HCC progression by means of targeting miR-187-3p/RTKN2 axis and initiating Wnt/β-catenin pathway33.